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Abstract
Only a small fraction of the mammalian genome codes for messenger RNAs destined to be 
translated into proteins, and it is generally assumed that a large portion of transcribed sequences - 
including introns and several classes of non-coding RNAs (ncRNAs) do not give rise to peptide 
products. A systematic examination of translation and physiological regulation of ncRNAs has not 
been conducted. Here, we use computational methods to identify the products of non-canonical 
translation in mouse neurons by analyzing unannotated transcripts in combination with proteomic 
data. This study supports the existence of non-canonical translation products from both intragenic 
and extragenic genomic regions, including peptides derived from anti-sense transcripts and 
introns. Moreover, the studied novel translation products exhibit temporal regulation similar to 
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that of proteins known to be involved in neuronal activity processes. These observations highlight 
a potentially large and complex set of biologically regulated translational events from transcripts 
formerly thought to lack coding potential.
Introduction
Recent genome-wide transcriptome studies have shown that tens of thousands of loci outside 
of the defined protein coding regions are transcribed1–3 . The resulting transcripts include a 
plethora of species such as 5’ leader sequences and 3’ end regions, introns, micro RNAs 
(miRNAs)4, enhancer RNAs (eRNAs)5, small nuclear RNAs (snRNA)6, anti-sense 
transcripts7–9, and various other short and long RNAs10. The identification of these 
transcripts implies a complexity previously unappreciated and has led to the emergence of 
significant efforts investigating the roles of RNA species traditionally referred to as non-
coding sequences11–12. In parallel to the identification of transcribed regions throughout the 
genome, proteomic studies have shown that a fraction of the "high-quality spectra" from 
mass-spectrometry (MS) based proteomics experiments do not match annotated proteins13. 
This led us to hypothesize that some of these unmatched spectra could represent 
uncharacterized translation events derived from transcribed regions outside coding genes. 
Consistent with this hypothesis, recent studies have shown that non-coding transcripts are 
associated with ribosome14 and that some non-coding transcripts lead to translation of short 
open reading frames15.
Here we report the results of a systematic study that we undertook to investigate and 
evaluate the existence of non-canonical translation products and their biological regulation 
under physiological conditions combining RNAseq and quantitative MS approaches. The 
results of this study not only indicate the presence of a large number of previously 
undetected protein translational products but they also show that they are temporally 
regulated suggesting more complex regulatory biochemical mechanisms that have not been 
previously observed.
Results
Work flow and analysis of RNAseq data
To systematically investigate the existence of non-canonical translation products and their 
biological regulation under physiological conditions, we introduced and validated new 
computational algorithms to compare the transcriptome and the proteome from the same 
experimental context (Supplementary Fig. 1). These algorithms were developed to identify 
transcripts and corresponding translation products from transcriptome data derived from 
sequencing total RNA (RNA-seq), including polyA and non-polyA species and mass 
spectrometry MS peptide sequencing data. The algorithms were applied to data collected 
from an experiment in which mouse cortical neurons were depolarized by potassium 
chloride (KCl) to induce activity-dependent expression changes (see Methods). Total RNA-
seq transcriptome data after rRNA depletion5 and quantitative MS proteomic data were 
collected at multiple time-points (Figure 1A). To identify transcribed regions from the total 
RNA data, a de novo transcript-calling algorithm was used16. This algorithm is well suited 
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to discover unannotated translation products, since it identifies unspliced transcripts, has no 
sequence biases, and is specifically designed to detect lowly expressed regions of the 
genome. The algorithm identified 26,169 transcribed regions, 12,108 of which overlapped 
with annotated protein coding genes (RefSeq, mm9). Here, regions corresponding to 
unspliced transcripts from total RNA data are searched; thus, our study has the potential to 
detect a wider range of non-canonical protein products and differs from previous work that 
was confined to either spliced transcripts15 or transcripts attached to ribosomes17.
IIdentification of novel non-canonical translational products
A multiplexed quantitative MS proteomic data set comprised of 3 biological replicates with 
3 technical replicates each, with a temporal profile similar to that of the transcriptomic data 
yielded 1,131,393 MS spectra. We used an iterative procedure to investigate these peptide 
fragmentation spectra. The rationale for this iterative strategy was to reduce the random 
matching spectra derived from annotated peptides to non-canonical sequences, thereby 
increasing the chances of identifying true spectral matches for non-canonical transcripts. 
First, the spectra were searched with MASCOT (v2.3) against an annotated mouse protein 
database (Uniprot Feb 2012, canonical and isoform sequences) to identify matches to 
annotated peptides; 226,471 (20%) of the spectra matched annotated sequences. These 
matched spectra (peptide spectral matches, PSMs) corresponded to 15,516 unique peptides 
and were grouped into 3,284 proteins using a 1% false-discovery rate (FDR) cut-off and a 
minimum of two peptides per protein (Figure 1B). Since the focus in this study was to 
investigate non-canonical translational events, the spectra matching the annotated proteome 
were then excluded before searching against the custom transcriptome database.
While unmatched good quality spectra may be derived from peptides which are post-
translationally modified and are not accounted for in the initial searches against the 
canonical mouse protein sequence database, we asked whether some of the unmatched good 
quality spectra could constitute translation products from transcripts classified as non-coding 
RNAs (ncRNAs). To investigate this possibility, the remaining un-matched spectra were 
searched against a custom database, which was generated by translating the transcribed 
regions from total RNA-sequence data. This custom database contained transcripts derived 
from total RNA, including unspliced RNAs and also annotated genes. Each transcript was 
searched in all six reading frames using MASCOT. A 1% FDR was used to select for high 
confidence PSMs resulting in 7,722 PSMs (Figure 1B) (of which 54% were non-redundant). 
To further restrict subsequent analyses to high quality matches, only the 1,584 matches with 
a MASCOT expectation value <0.05 were chosen for further analysis. The expectation value 
is equivalent to the E-value in a BLAST search and thus gives each PSM a probability 
estimate for being a random match. These parameters provide confidence that these hits 
represent true positives, even though in some cases only a single instance of a peptide is 
detected18. The set of 1,584 PSMs comprised 250 distinct peptides that mapped uniquely to 
regions of the mouse genome considered non-coding (Supplementary Table 1). Seven pairs 
of peptides (Supplementary Table 2) matched two different non-coding RNAs that differed 
only by an isobaric I/L amino acid, while the unambiguous identification of the source of 
these peptides is not possible, it is clear that these peptides sequences are not found in the 
canonical mouse protein sequences. Given that RNA sequence information was obtained for 
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both I and L containing peptides, it is possible that both the I and the L containing peptides 
are present; therefore, all 14 peptides were included for further analysis. Interestingly, both 
annotated and novel peptides were found for some proteins. For example the initial database 
search against the annotated Uniprot database resulted in the identification of 9 annotated, 
unique peptides for Centg2 (Agap1, Supplementary Figure 2), (17% protein sequence 
coverage); whereas the database search against the custom transcriptome database resulted 
in the identification of two novel peptides from the first intron of Centg2 (Agap1, 
Supplementary Fig. 2). The 250 high confidence peptides that were aligned to 
experimentally defined transcripts are referred to as novel peptides throughout the 
manuscript (Figure 1B).
Evaluation and validation of novel peptides
In addition to the high stringency cut-offs used to select peptides, several experiments were 
performed to evaluate the novelty of the peptides and the validity of the PSMs. First, each of 
the 250 novel peptide sequences was searched in non-redundant protein sequences from 
mouse using BLASTP and the UCSC genome browser. The results showed that 31 of the 
peptides corresponded to either pseudogenes or unannotated genes, which had been 
predicted to be translated, based on computational and transcriptional evidence, but lacked 
any supporting protein evidence. None of the remaining 214 peptides showed a similarity to 
the annotated proteome (Supplementary Table 1). Second, each of the 250 novel peptide 
sequences was searched against both the peptide atlas (http://www.peptideatlas.org) and 
NIST-Libraries of Peptide Tandem Mass Spectra (http://peptide.nist.gov) databases. None of 
these novel peptides were identified in those databases, confirming that the novel peptides 
had not been reported in publicly available databases. Third, synthetic peptides were used to 
chemically validate the identity of the novel peptides. Fragmentation patterns of the 
synthetic peptides were compared with the mouse peptides identified from the primary 
dataset. This is the most stringent method available for validating an identified peptide as it 
constitutes a chemically synthesized positive control. The fragmentation patterns of 45 
peptides are presented (Figure 2E, Supplementary Fig. 2B, Supplementary Fig. 3, and 
Supplementary Fig. 5B and Supplementary Fig. 7C). The similarity between the identified 
and synthetic spectra was evaluated by computing the rank-ordered Spearman Correlation 
coefficient; all the peptides showed strong correlation with a significant p-value (p<0.05). In 
addition, the average number of common fragment ions identified was greater than 90%. 
Fourth, the 250 novel peptides were compared against published results from a ribosomal 
foot-printing experiment14. Of note, the ribosomal profiling data were performed on mouse 
embryonic stem cells, which have a different expression profile from mouse neurons. 
Nonetheless, 34 of the novel peptides were observed to be associated with ribosomes, 
providing independent evidence consistent with non-canonical translation events. These 
analyses and validation procedures lend support to the current proof-of-existence of novel 
peptides from non-canonical translational events.
Molecular characterization of FARP1
Further in-depth molecular characterization of non-canonical translation was carried out for 
the FARP1 protein. Two unique novel peptides DGIRPSNPQPPQPSTGPASR and 
HSSLIDDMR, which were in frame with the rest of the protein, were mapped to the FARP1 
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intron 13 (Figure 2A). The RNA-seq read density across this intron is ~10-fold higher than 
that of the other introns and the RNA levels for this intron are comparable to the levels 
observed for the exons (Figure 2B). In addition, RT-PCR from three regions of this intron 
showed good expression in cortical cells from same experimental set up (Figure 2C). Closer 
inspection of the FARP1 intron 13 sequence reveals that the first 983 bps do not contain a 
stop codon within the reading frame used by the preceding exon. Thus, we hypothesized that 
there could be novel isoforms present with ~330 additional amino acids. Western blot (WB) 
validation was performed to investigate FARP1 (F8VPU2) in brain lysates. FARP1 is 
FERM, Rho-GEF, pleckstrin domain containing protein with several different splice variants 
and varying molecular weights ranging from 51 kDa to 420 kDa (Figure 2D). To validate 
that FARP1 isoforms are present in the protein bands corresponding to the western blots, an 
immunoprecipitation (IP) from mouse brain tissue followed by MS analysis was performed. 
Briefly, when the IP of FARP1 is separated by size on an SDS PAGE gel and stained using 
coommassie blue, protein bands are observed at molecular weight ranging from 51 kDa to > 
420 kDa as observed from WB results of the whole cell lysate (Figure 2D). These bands 
were excised and analyzed by LC-MS/MS. The resulting data was searched against the 
Uniprot mouse proteome database appended with the FARP1 (F8VPU2) intron sequence 
that was identified as a translation product in the global proteomics experiment. The novel 
peptides from the presumed intron were identified in three of the bands as indicated in 
Figure. 2D. This extensive validation using IP and MS suggests that the bands observed in 
the WB do indeed contain various splice variants of FARP1, some of which include the 
novel intron. Furthermore, the fragmentation pattern of one of the novel peptides identified 
for FARP1 (Figure 2E) matches that of its synthetic peptide. Taken together, the 
transcriptional and translational evidence suggest that this novel intron region is part of a 
larger unannotated variant of FARP1. The WB validation lends support to the genome-wide 
strategy for discovering novel non-canonical translation events. To predict the functional 
consequences of this large novel intron in the FARP1 protein, a disorder prediction analysis 
(http://iupred.enzim.hu) and domain mapping (SMART) was carried out. These analyses 
predicted a highly disordered region for this novel intron and domain mapping using ELM 
(http://elm.eu.org) indicated numerous regulatory regions in this novel intron sequence when 
compared to the whole sequence. Figure 2F illustrates the quantitative estimation of a subset 
of regulatory regions which is enriched in the novel intron as compared to the entire protein 
sequence suggesting that this region is possibly a hotspot for regulation by post-translational 
modifications. Additionally, ribosomal foot-printing data and RNA-seq data from HeLa 
cells provide further support for the expression of this FARP1 intron (Supplementary Fig. 
4).
Mapping of novel peptides to genomic regions
The novel peptides were mapped to their genomic origins, and compared with existing 
annotations and the RNA-seq data. These comparisons led to a categorization of the novel 
peptides into 5 sub-groups (Figure 3). Forty-nine of the novel peptides belonged to the set of 
peptides identified in the BLASTP search or were derived from 5’ leader sequences or 3’ 
end regions (Group 1). A second group comprised 31 peptides that mapped to annotated 
pseudogenes (Group 2). Ten of the peptides in this group were also identified in the 
BLASTP search as having computational evidence suggesting protein-coding potential. This 
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result is consistent with previous studies showing that pseudogenes can be translated19 
(Supplementary Fig. 5). A third group, (Group 3) included 79 peptides that mapped onto 
introns. These examples may reflect the existence of unannotated exons or intron inclusion 
events. One such example is the FARP1 locus discussed above. A particularly intriguing and 
unexpected group of 66 peptides (Group 4) mapped onto the reverse strand from (n = 63) or 
near (n = 3) known exons and introns in protein coding genes. Three of the peptides were 
found in the region upstream of the promoter, suggesting that they are derived from 
upstream anti-sense RNAs8 in mouse cortical neurons16. One example is Flnb 
(Supplementary Fig. 6), which shows evidence of a ~5 kb long anti-sense transcript based 
on our RNA-seq data as well as RNA-seq data in both the mouse liver and kidney20. To 
validate the expression levels of a subset of identified ‘hit’ transcripts, total RNA was 
isolated, tested for its integrity and reverse transcribed (Supplementary Table 3 and 
Supplementary Fig. 7A). Sequence verification confirmed the presence of the targeted anti-
sense transcripts (Supplementary Fig. 7B). One of the novel peptides anti-sense to Cox17 
(IILMPSLPAR), located on chromosome 16 overlapping but anti-sense to its second intron 
was validated by synthetic peptide validation as discussed above (Supplementary Fig. 7C). 
All of the novel peptide groups described above were located within or in the vicinity of 
known protein-coding genes. Finally, a second unexpected set consisted of 25 peptides that 
mapped onto extragenic regions removed from any known protein-coding gene were found 
(Group 5). Three of these peptides were also found in the ribosomal foot-printing data14.
Quantitative analysis of the novel peptides
Having determined the genomic context of the novel peptides, we set out to determine 
whether they were physiologically regulated in response to enhanced neuronal activity. 
Neuronal activation induces a gene expression program involving several hundred genes as 
well as non-coding RNAs5. In the experimental setup (Figure 1), mouse cortical neurons 
were stimulated using KCl, and TMT labeling were used to quantify the relative abundance 
of each peptide at different time-points following KCl stimulation. For each TMT channel 
the same amount of protein, 100 µg, was used, and labeling bias was tested by assessing the 
median of log2 intensities from all the channels (Supplementary Fig. 8). The medians across 
the channels had a standard deviation of 0.16 and a coefficient of variance of 0.02. This 
suggests that there is no inherent mixing irregularities in the total pool of labeled sample and 
the differential peptide abundance observed among time-points are true observations and 
hence could be biologically relevant. In addition, TMT labeling efficiency was evaluated to 
be 99.5% of all unique and high-confidence peptides of which 98.3% are fully labeled 
(labeled on N-terminal and internal Lysine residues) with TMT reporter ions indicating that 
there is no significant loss of peptides that would affect quantitation. All the above 
validations highlight our careful and comprehensive assessment of the quantitative changes 
of the novel peptides and hence indicate that the abundances of the known proteins 
(Supplementary Fig. 9) and novel peptides (Figure 4) are modulated by KCl depolarization.
To identify patterns of co-regulation between the known proteins and novel peptides, the 
known protein abundance changes along with the novel peptide abundance changes were 
clustered together in an unbiased way using GProX (version 1.1.12) software. Results of the 
clustering analysis indicate that eight clusters identify discerning patterns of co-regulation of 
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known proteins and novel peptides (Figure 4B). The number of novel peptides in each of the 
clusters is listed in Figure 4B. Extrapolating from this data and from our own previous 
analyses21–22, it can be predicted that these novel peptides are co-regulated in similar 
manner as the known proteins in each of the clusters. Some of these known proteins include 
CamKIId, Gria1 and Shank2, that are known to be temporally regulated with KCl 
stimulation in neurons.
Discussion
Using a custom unprocessed transcriptome database from the same experimental context as 
reported here for the unbiased examination of the proteome, is a robust means to identify the 
existence of peptides derived from regions classified as non-coding throughout the genome. 
Although it is possible that some of these non-canonical peptides are the result of biological 
noise, this interpretation would require “errors” at multiple levels including: transcriptional 
sloppiness by RNA polymerase, followed by the stable survival of non-polyA transcripts, 
export of these species into the cytoplasm, recognition by the ribosomal machinery and 
translation. The consistency of the findings, which are derived from pooling large numbers 
of cells, together with the validation, cast doubt on an interpretation purely based on 
biological noise. Instead, the discovery of non-canonical translation products and the 
validation of 250 novel peptides is consistent with several different lines of evidence, 
including ribosomal profiling studies14, characterization of short open reading 
frames19,23–25 and studies examining translation of pseudogenes26, which have pointed to a 
more extensive proteome than what is described by current databases. Most MS analyses, 
including the one presented here, are not saturating, and the number of detected protein 
products is much lower than the number of mRNAs detected by RNA-seq. Our RNA-seq 
data identified ~12,000 transcripts corresponding to canonical protein sequences, the 
proteomics data gave evidence for ~25% of the canonical transcripts. Extrapolating from 
this observation, it can be estimated that at least 4 times as many novel peptides are yet to be 
discovered under the current experimental conditions. Furthermore, it can be speculated that 
examining other tissues and biological conditions will uncover an even richer set of non-
canonical translational events.
The biological function, if any, of the novel peptides described here is not known. Several 
studies have suggested that evolutionarily conserved regions are more likely to be 
functionally important. Sequence conservation for the 250 novel peptides was investigated 
in 28 vertebrate species using the MultiZ alignment27. The results show that there are 30 
peptides with significant evidence of purifying selection (Supplementary Table 1), and that 
the translated sequences found in many species are more likely to show evidence of 
purifying selection (Supplementary Fig. 10), consistent with studies of proto-genes in 
yeast28. The observation that peptides derived from non-canonical translational events show 
dynamic regulatory patterns under physiological conditions similar to those characterized 
for well-established proteins further suggests the possibility that these peptides may also 
play functional roles. Future examination of other tissues and conditions combined with 
functional studies will shed light on the biological roles of the uncharted proteome.
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Methods
Brief overview of the experimental design and Mass Spectrometry analysis (MS)
Neuronal cultures were grown, depolarized with potassium chloride (KCl) for 0, 1, 2, 3 and 
6 hrs (three biological repeat experiments were performed independently). Proteins were 
extracted and digested into peptides from neuronal cell lysates of each time point. Peptides 
from the 5 time-points in each experiment were labeled with 5 different isobaric MS labels 
as follows: TMT-127 for 0 h, TMT-128 for 1 h, TMT-129 for 2 h, TMT-130 for 3 h and 
TMT-131 for 6 h (TMT-126 was used to label pre-stimulated neurons). After labeling, the 
peptides were pooled together and separated based on their isoelectric point differences into 
24 fractions. Hence a total of 24 * 3 = 72 fractions were collected and analyzed by MS. Each 
sample was analyzed 3 times by LC-MS/MS (at least 3 technical repeats were performed 
resulting in 238 MS raw data files (with a few re-analyzed). These 238 files were grouped 
and then searched against mouse database. Un-matched peptides to the mouse database were 
then exported and searched against the custom RNA seq database in 6 frames. After 
stringent filtering of the results, peptides designated as novel peptides were further validated 
by computational and biochemical methods including synthetic peptide matching, RT-PCR, 
western blotting (WB), Immune-precipitation (IP) confirmed by MS and bioinformatics 
analysis. Each experiment is described in detail below.
Animals
All experimental procedures were performed in compliance with animal protocols approved 
by the IACUC at Children's Hospital Boston, Boston, MA. We used embryos at age E16 
from the C57BL6 mouse strain for neuronal cultures.
Mouse cortical cultures
Cortices of the mice embryos (C57BL/6, Charles River) at stage E16.5 were dissected and 
dissociated in 1× Hank’s Balanced Salt Solution (HBSS) (14175-046, Life Technologies), 
100 mM MgCl2, 10 mM Kynurenic acid, 100 mM HEPES, 20 mg/ml trypsin (LS003736, 
Worthington Biochemicals) and 0.32 mg/ml L-cysteine (C7352, Sigma) for 10 min. Trypsin 
treatment to dissociate cells was terminated with three 2 min washes in 1× HBSS with 10 
mg/ml trypsin inhibitor (T6522, Sigma). Cells were triturated with a flame-narrowed Pasteur 
pipette for complete dissociation. Neurons were seeded at an approximate density of 4×107 
on 15 cm dishes. The dishes were pre-coated overnight with 30 µg/ml poly-ornithine 
(P8638, Sigma) in water, washed three times with autoclaved water, and washed once with 
Neurobasal Medium (21103049, Life Technologies) before use. Neurons were maintained in 
30 ml filtered Neurobasal Medium containing 1 M Glucose, B27 supplement (17504-044, 
Invitrogen), penicillin-streptomycin (50 µg/ml penicillin, 50 U/ml Streptomycin, P0781 
Sigma) and 1 mM Glutamine (G6392, Sigma). Neurons were grown in vitro for 7 days. 
Eight ml of the medium was replaced with 10 ml fresh warm medium on the 4th and 6th 
days.
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Potassium chloride depolarization of neurons
Neuronal cultures at day 6 were treated overnight with 1 µM Tetrodotoxin (TTX, 1078, 
Tocris) and 100 µM D(-)-2-amino-5phosphonopentanoic acid (D-AP5, 0106, Tocris) and 
cells were collected at 0, 1, 2, 3 or 6 hrs after incubation with 55 mM KCl in culture media.
TMT labeling and peptide fractionation
Cells were lysed on ice for 10 min using lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 1% NP-40, 1 mM PMSF) containing protease inhibitors (Roche-complete protease 
inhibitor cocktail tablets) and phosphatase inhibitors (Sigma phosphatase inhibitor cocktails 
I and II). Cells were passed through a 27G needle multiple times, sonicated briefly, and 
centrifuged for 30 min, 4 °C at 20,000 g to clear the solution. Clear lysates were collected, 
transferred to new tubes and protein concentrations estimated using a BCA assay kit (23225, 
Thermo Scientific). Protein precipitation and digestion was carried out as described by 
Winter et al., 201129. Briefly, 100 ug of protein was precipitated from each time point using 
1ml of ice cold chloroform/methanol. The pellets were re-dissolved in 0.1 % Rapigest 
(186001861, Waters) in 100 mM TEAB (triethyl ammonium bicarbonate), 17902, Sigma), 
and incubated at 37 °C for 15 min. Trypsin (V5280 Promega) was added to the samples and 
incubated at 37 °C for 45 min to dissolve the pellet. Samples were reduced with 20 mM 
DTT for 60 min at 56 °C and alkylated with 1 % acrylamide for 45 min at room temperature 
(RT). Further trypsin was added to a final enzyme to protein ratio of 1:100 and the mixture 
was incubated at 37 °C overnight. Peptide samples from each time point were acidified 
using 5 µl trifluoroacetic acid (TFA) and incubated for 45 min at 37 °C in order to 
precipitate the RapiGest followed by centrifugation for 30 min at 20,000 g. Clear 
supernatants were desalted using Oasis HLB cartridges (186006339 Waters). Briefly, the 
columns were washed twice with 70 % ACN 0.1 % Formic acid (FA) and twice with 0.1 % 
FA. The sample pool was passed twice through each individual column, washed with four 
times with 0.1 % FA and eluted twice with 30 % ACN 0.1 % FA, twice with 50 %ACN 0.1 
% FA and twice with 70 % ACN 0.1 % FA. Individual eluate fractions were pooled and 
samples dried in a vacuum centrifuge. Dried samples were re-suspended in 0.1M TEAB and 
peptide concentrations quantified using the BCA assay. For each sample, peptides from 
different time-points after KCl stimulation were labeled with one of the 5 TMT labels 
(PI-90064, Thermo Fischer Scientific) for 3 h at room temperature (RT) following the 
manufacturer's protocol. The samples were combined, partially dried using a vacuum 
centrifuge and desalted using Oasis HLB cartridges as described above. The dried peptides 
were resuspended in ampholyte solution (pI 3–10) and fractionated overnight into 24 
fractions based on their isoelectric point using an OFFGEL fractionator (Agilent) according 
to the manufacturer’s instructions. The fractions were desalted and analyzed using LC-
MS/MS.
MS analysis
Peptide samples were loaded directly onto an in house packed reverse phase column using 5 
µm, 200Å particles (magic C18, Michrom) and PicoTip Emmiters (New Objective) with an 
autosampler / nanoLC setup (2D nanoLC, Eksigent) at a flow rate of 1 µl/min. After loading 
the column was washed for 5 min at 1 µl/min at 99 %A (water with 0.2 % FA) 1 %B 
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(acetonitrile with 0.2 % FA) followed by elution with a linear gradient from 1 % B to 35 % 
B at 400 nl/min in 60 min. Peptides eluting from the column were ionized in the positive ion 
mode and the 6 most abundant ions were fragmented in the PQD-mode30 to allow for the 
detection of low mass range reporter ions. Briefly, the LTQ-Orbitrap was run in positive ion 
mode. Full scans were carried out with a scan range of 395 to 1200 m/z. Normalized 
collision energy of 35 was used to activate both the reporter ions and parent ions for 
fragmentation. Scans were carried out with an activation time of 30 ms. The isolation 
window was set to 1.0 m/z.
Testing labeling efficiency
For each of the TMT channels equal amounts of protein, 100 µg, were used. Labeling bias 
was tested by assessing the log2 intensities from all the channels (Supplementary Fig. 8). 
The median across the channels had a standard deviation of 0.16 and a coefficient of 
variance of 0.02, suggesting that there is no inherent mixing irregularities in total pool of 
labeled sample and the differential peptide abundance observed among time-points are true 
observations. In addition TMT labeling efficiency was evaluated to be 99.5% of all unique 
and high-confidence peptides of which 98.3% are fully labeled (labeled on N-terminal and 
internal Lysine residues) with TMT reporter ions. The labeling efficiency of fully labeled 
peptides and the median intensities calculated for each channel indicate that there is no 
quantitative bias that would affect the results reported in the profile data.
MS data analysis
The proprietary Thermo Scientific .raw files (238 in total as explained above) were 
converted into 6 .mgf files and MS/MS data was queried against the Uniprot Feb 2012, 
(canonical and isoform sequences) protein sequence database, containing common 
contaminations and concatenated to its decoy version, using MASCOT v2.3 (Matrix 
Science). TMT peptides were searched with enzyme specificity trypsin, two missed cleavage 
site, carbamidomethyl (Cys), oxidation (Met), deamidation (N), and Gln to pyro Glu (N-
terminal Q), phosphorylations on S/T/Y and TMT-6plex (N-termini and Lys) as variable 
modifications. Only 226,471 (20%) of the spectra were matched to the mouse database 
resulting in 15,516 peptides that were unique. They were grouped into 3,284 proteins with a 
1% protein false-discovery rate (FDR) cut-off for proteins and at least 2 peptides per protein 
were identified. This corresponded to a Mascot cut-off score of 26.93 and above for each 
protein.
The remaining 904,922 (80%) unmatched spectra were exported and searched against a 
custom database generated from RNA seq data comprising all the transcribed regions16. The 
nucleotide database was concatenated to common contaminants and its decoy version and 
searched using MASCOT v2.3 in all 6 frames with the following parameters: enzyme 
specificity trypsin, two missed cleavage site, carbamidomethyl (Cys), oxidation (Met), 
deamidation (N), and Gln to pyro Glu (N-terminal Q) and TMT-6plex (N-termini and Lys) 
as static modifications. A stringent 1% local FDR was used to select for high confidence 
matched spectra resulting in 7,722 matched spectra (peptide spectral matches). To further 
ensure that only high quality matches were included, only the 1,584 matched spectra with an 
expectation value <0.05 were chosen for further analysis. The expectation value is 
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calculated by the search engine (MASCOT v2.3), and it is equivalent to the E-value in a 
BLAST search. In total, there were 250 distinct peptides that mapped uniquely to the mouse 
genome and did not overlap with the 3,284 proteins. This set of high confidence unmatched 
peptides that are matched to experimentally defined nominally noncoding transcripts is 
referred to as novel peptides.
Synthetic Peptide labeling and validation
Synthetic peptides (JPT Peptide Technologies) were dissolved as per instruction. These 
peptides were pooled in equimolar concentration and categorized in six groups. Each peptide 
group was mixed with one of six TMT labels (Thermo Scientific) for 3 hours at RT. The 
reactions were quenched with 5 % hydroxylamine in 100 mM TEAB and incubated for 15 
min at RT. The samples were desalted with micro spin Silica C18 columns (Nest Group, 
Inc.) following manufacture’s guidelines. Briefly, the columns were washed twice with 70 
% ACN (with 0.1 % FA), washed twice with 0.1 % FA. The sample pool was passed twice 
through each individual column, washed four times with 0.1 % FA and eluted twice with 30 
% ACN (with 0.1 % FA), twice with 50 % ACN (with 0.1 % FA), twice with 70 % ACN 
(with 0.1 % FA). The eluted fractions of each individual pool were combined and dried in a 
speed-vac (Thermo Scientific) at room temperature. The pellet was re-dissolved in 5 % 
ACN (with 5 % FA) loading buffer and analyzed on 4 different instruments: a Q-Exactive 
(Thermo scientific): and on three instruments capable of PQD- an Orbitrap Elite (Thermo 
scientific), and 2 Orbitrap Velos at Beth Israel and Deaconess Medical Center and at the 
University of Bonn (Thermo scientific). The .raw files were searched against the custom 
RNA-seq database.
The spectra and the fragmentation pattern for each of the synthetic peptides were compared 
and validated to the ones from the experiment, denoted as ‘identified’. Briefly, the top 90 % 
matched fragment ions were compared between the synthetic peptide spectra and identified 
peptide spectra using Spearman rank-order correlation analysis. All the correlations were 
checked for a significant p-value of 0.05 or less and positive correlation coefficient for all 
the instrument types. Finally, the matched y and b ions indicated by their respective 
fragmentation tables were also mapped.
RT-PCR validation
Total RNA isolation for RT-PCR validation was done using mirVana isolation kit (AM1560, 
Ambion). We collected and combined 0, 1, 2, 3, 6 hrs post-KCl stimulation time points for 
cortical neuron cultures that were plated in equal density. Cells were washed with PBS, 
lysed on ice with vortexing in lysis/binding solution as per the manufacturer’s instruction. 
The lysate was treated with 1/10 volume of miRNA homogenate additive for 10 min on ice 
and was organically extracted with acid-phenol:chloroform mixture. The aqueous phase was 
recovered and mixed with 1.25 volumes of 100 % ethanol. The mixture was further purified 
through filter cartridge, washed and eluted with nuclease free water. The RNA eluate was 
analyzed (Agilent 2100 bioanalyzer nano series) to determine high quality, intact RNA 
without DNA contamination and concentration was determined using a nanodrop 
spectrophotometer (Supplementary Fig. 7A). First strand cDNA was synthesized using 
SuperScript First-Strand synthesis system (11904-018, Invitrogen). Briefly, total RNA 
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sample was incubated with random hexamer primers to include all RNA for cDNA synthesis 
and dNTP mix at 65 °C for 5 min, then placed on ice for 1 min. The sample was mixed with 
2× reaction mix of Reverse transcription buffer, MgCl2, DTT and RNAaseOUT and 
incubated at room temperature for 10 min, then incubated at 42 °C for 50 min. The reaction 
was terminated by heating at 70 °C for 15 min, then on ice. To ensure the sensitivity of 
PCR, the cDNA-RNA hybrid molecule was treated with RNase H at 37 °C for 20 min. The 
cDNA was then used to amplify specific novel regions of selected length containing peptide 
match regions identified using the mass spectra and deep sequencing data. Primers were 
synthesized with IDT custom oligo, designed using OligoPerfect designer (Invitrogen) and 
Tm was optimized using Finnzyme calculator (Thermo scientific). Supplementary Table 3 
lists the regions of interest and primers sequences. PCR was performed using Phusion HF 
buffer, dNTPs mix, Phusion hot start DNA polymerase with initial denaturation at 98 °C for 
30 sec, denaturation at 98 °C for 10 sec, annealing at Tm of the lower tm primer (for 20 
nucleotides or less) and 3 °C higher than the Tm of lower tm primer (for more than 20 
nucleotides) for 30 sec, extension at 72 °C for 30 sec / kb template length and 30 cycles. 
Final extension was done at 72 sec for 10 min, followed by 4 °C. The PCR products were 
run on 1 % agarose with ethidium bromide in 1× TAE buffer (Figure 2C, Supplementary 
Figure 6B). Products were gel purified using QIAQuick PCR purification columns (28104, 
Qiagen) and sequenced conventionally. The results were mapped to the template region 
using the ClustalW2 (EMBL-EBI) tool and translated into 6 frames using ExPASy tool to 
validate for peptides match.
FARP1 Immunoprecipitation (IP) and western blot analysis
Whole brain tissue was lysed in buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% NP-40, 
0.5% sodium deoxycholate, 0.1% SDS, 0.004 % sodium azide, protease inhibitors tablet) 
using bead beater homogenizer (Precellys) for 6800 rpm, 3× 15 sec with 60 sec rest cycle. 
The lysate was centrifuged at 14,000 rpm, 10 mins at 4 °C. FARP1 antibodies K-20 
(sc-74927, 2 ug per 500 ug of lysate for IP, 1:500 for WB, Santa Cruz Biotechnology) and 
FARP1 H-300 (sc-98722, 2 ug per 500 ug of lysate for IP, 1:500 for WB, Santa Cruz 
Biotechnology) were tested separately for IP and incubated with lysate for 2 hours. The 
immuno-complexes were pulled-down using protein A/G agarose beads (Santa Cruz) in an 
overnight incubation with rotation. The beads were pre-blocked with BSA to reduce non-
specific immunoglobulin binding. The immune-precipitates were sedimented at 1000 g, 5 
min, 4 °C. The beads were washed 4 times with RIPA buffer containing 150 mM salt. The 
beads were resuspended in laemmli buffer containing β-mercaptoethanol and boiled for 3–4 
min. The lysate and IP eluate samples were run on 4–12 % SDS-PAGE gel (NP0335BOX, 
Invitrogen) and were subjected to western blot analysis using the FARP1 primary antibody 
K-20 (sc-74927) as a probe in dilutions described above. A secondary goat anti-rabbit IgG-
HRP antibody (sc-2054, 1:5000 dilution was then used for the WB, Santa Cruz 
Biotechnology). The WB was developed by Super Signal West Pico chemiluminescence kit 
(34080, Pierce). The commassie stained gel bands were analyzed by MS MS. The peptides 
were extracted, reduced with DTT, alkylated with iodoacetamide and digested with trypsin 
before running on a QE instrument with a 60 min gradient to acquire a base peak 
chromatogram intensity of e9 - e10. The raw files were converted into .mgf files and 
searched using mouse proteome database (Uniprot Feb 2012, (canonical and isoform 
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sequences) protein sequence database, containing common contaminations and concatenated 
to its decoy version, using MASCOT v2.3 (Matrix Science) appended with mouse FARP1 
Uniprot identifiers and intron region (983 bases) in coding frame using ProteinPilot search 
engine software v4.5.1. The data was analyzed to identify peptides from FARP1.
Bioinformatics analysis
Each of the 250 peptides reported in Supplementary Table 1 were inspected manually using 
the UCSC Genome browser. In addition to using the ChIP-Seq and RNA-Seq data from 
mouse neurons, the RNA-Seq data from the mouse ENCODE was also used20. The initial 
assignment into different categories was carried out by an algorithm, and the assignment 
was based on the location of the transcribed region and peptide relative to known genomic 
features. In some cases the category was changed following the manual inspection.
Clustering of novel peptides and known proteins
The intensities for each peptide were normalized by dividing the values at 1 hrs, 2 hrs, 3 hrs 
and 6 hrs by the value at 0 hrs. Next, we carried out unsupervised hierarchical clustering of 
the log2-values for the temporal profiles using Matlab's "clustergram" function. The 
clustering was based on the Euclidean distance between the intensity profiles and the same 
settings were used for the known (Supplementary Figure 9) and the novel peptides (Figure 
4A).
Co-clustering of novel peptides and known proteins
To identify patterns of co-regulation between the known proteins and novel peptides, the 
known protein abundance changes along with the novel peptide abundance changes were 
clustered together in an unbiased way using GProX (version 1.1.12) software. Results of the 
clustering analysis indicate that eight clusters identify discerning patterns of co-regulation of 
known proteins and novel peptides (Figure 4B). The number of novel peptides in each of the 
clusters is listed in Figure 4B. All ratios in each experiment were standardized before 
clustering (the mean was deducted from the values and divided by their standard deviation). 
The membership scale reflects how well the regulation of a protein matches the consensus 
profile.
Ribosomal foot-printing analysis
Ribosomal footprinting data for elongating ribosomes for mouse embryonic stem cells was 
downloaded from gwips.ucc.ie. To identify peptides with significant levels of ribosomal 
footprinting reads, the peptide positions were first converted to mm10 coordinates, and then 
all peptides with 5 or more reads within 200 bps were extracted. Based on manual inspection 
in the genome browser at gwips.ucc.ie, 34 loci were determined to have evidence of 
ribosomal interactions.
Phylogenetic comparison
The MultiZ alignment for 28 species relative to mm9 was downloaded from the UCSC 
website. Around 142 peptides were found in alignment blocks by MultiZ, and the 
orthologous sequences for all other species that aligned to the same block were extracted. 
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For each aligned peptide, the codons with one substitution were classified as either 
synonymous (S) or non-synonymous (N), and the total number of synonymous (dS) and 
non-synonymous (dN) events were recorded. For each peptide, the ratio dN/dS were 
calculated (Supplementary Fig. 10) and a value <1 is characteristic of purifying selection.
As a control, for each peptide a sequence of the same length starting 1000 bps downstream 
was extracted. Since only a few annotated exons in the mouse genome are longer than 1 kb, 
it is highly unlikely that the control sequences will be part of the same exon as the novel 
peptide. Thus, there is only a 1/3 chance that the control sequence will be in frame. To 
compensate for the fact that the frame of the controls is not known, the sequences starting 
1001 and 1002 bps downstream were also extracted, and for each codon, the frame with the 
lowest dN/dS ratio was selected. This strict control did not have as many codons with dN/
dS<1 as the data (Supplementary Figure 10), suggesting that the difference between the data 
and the control are real. To determine the threshold for when dN/dS is significant, the largest 
value where the number of peptides in the data is no longer at least 10 times larger than the 
control was chosen (the threshold chosen was 0.8).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Overview of the experimental procedure and peptide identification. (A) Work flow of the 
KCl depolarization experiment illustrating the collection of total RNA and protein from 
mouse cortical neurons. Protein samples from multiple time points after depolarization were 
digested, labeled with isobaric tags and analyzed by quantitative proteomic analyses (Liquid 
Chromatography Mass Spectrometry-LC-MS). (B) The resulting spectra were subjected to 
the database search procedure for filtering and matching peptide spectra. 20% of the spectra 
matched to the known mouse proteome (Uniprot Dec. 12th, 2011, incl. canonical and 
isoform sequences). The remaining 904,922 spectra were searched against the custom RNA-
Seq transcriptome database in 6 frames and the resulting matched spectra were filtered using 
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stringent criteria as mentioned in the text and of these 250 novel peptides were selected for 
further analyses. The custom transcriptome was derived from the same samples described.
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Figure 2. 
Identification and validation of two novel peptides at the FARP1 locus. (A) Screenshot from 
the UCSC genome browser showing total RNA, ribosomal footprints, Refseq gene structure 
and degree of conservation (Phast Cons). The bottom part is a zoomed in version spanning 
intron 13. The arrows indicate the position of the two novel peptides. The first peptide 
(DGIRPSNPQPPQPSTGPASR) spans an exon-intron boundary; the underlined amino acids 
are located within the intron. The figure also indicates peptides found from ribosomal foot-
printing studies (B) Average read density (RPKM) for all FARP1 introns. (C) RT-PCR gel 
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showing RNA expression of three regions within FARP1 intron from depolarized cortical 
cells. (D) Western blot analysis of mouse brain lysate showing FARP1 protein bands of 
different molecular weights. Coommassie stained SDS-PAGE gel showing 
immunoprecipitated (IP) of FARP1 from mouse brain lysate. The bands were analyzed using 
LC-MS/MS and confirmed as FARP1 (F8VPU2) protein along with peptides from intron 
(the full gel images of Figure 2C and Figure 2D are in Supplementary Figure 11). (E) 
Chemical validation of one of the novel peptides (HSSLIDDMFR) from FARP1 by 
comparing its spectra with synthetic peptide spectra as described in the methods. The 
identified peptide (HSSLIDDMFR) spectra (top) and synthetic peptide spectra (bottom) 
show a strong match with a spearman correlation coefficient (ρ) of 0.51 and a significant p-
value of 1.4e-04. The charge state, m/z value, p value and rho value of the peptide are listed. 
Overlapped fragmentation table indicating the y and b ions that were detected in both 
‘identified’ and ‘synthetic’ spectra. The green ions were detected in both spectra, blue were 
detected only in ‘identified’ spectra (F) A model showing the domains, disordered regions 
and regulatory regions prediction in FARP1 amino acid sequence including the novel coding 
region of intron 13 by ELM (http://elm.eu.org/). The total number of regulatory regions per 
100 amino acids is shown by line graph, out of which the distribution of a subset of 
functionally important regions per 100 amino acids are indicated by color bars. The number 
of regulatory regions is enriched in Intron 13 coding region.
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Figure 3. 
Classification of novel peptides based on their genomic location. The top panel depicts the 
two DNA strands of a canonical protein-coding gene with exons (green boxes), introns (red 
lines), and the transcribed sequences before the first exon and after the last exon (gray lines, 
here referred to as 5’UTR and 3’UTR). The 250 novel peptides were divided into 5 groups 
based on their location relative to known genes. The peptide location is denoted here by blue 
boxes. The number of peptides in each group is indicated. In the last group (extra-genic) the 
line is cut to indicate that there is a large distance (>10 kb) from the protein-coding gene. 
TSS = transcription start site.
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Figure 4. 
Quantitative regulation of novel peptides. A. Hierarchical clustering of the relative 
abundance temporal profiles for novel peptides (250 peptides). Each row represents one 
peptide. The four columns indicate abundance at 1 h, 2 h, 3 h and 6 h post KCl stimulation. 
The colors represent up- or down-regulation with respect to the 0 h time-point (see color 
map on left, arbitrary units). The clustering reveals several distinct regulatory patterns 
present both for known and novel peptides. These regulatory patterns are similar to those 
shown for known proteins in Supplementary Figure 8. (B) Clusters of both known proteins 
and novel peptides showing similar temporal regulation post KCl stimulation. The numbers 
of novel peptides in each cluster is indicated. The membership scale reflects how well the 
regulation of a protein matches the consensus profile.
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